The dosing interval for COVID-19 vaccines has become a hot topic of debate among scientists, regulators, and governments.
Britain has also decided to allow a longer gap between doses of a COVID-19 vaccine from Pfizer and BioNTech, even though the companies say they only have efficacy data for a shorter period between shots. While Sinovac’s researchers had said early stage trials showed a four-week interval induced the stronger antibody response than two weeks, this is the first time the company has released efficacy data from a Phase III trial with dosing patterns that differ from its trial protocol.
Reuters Lol, sinovac says its vaccine is more effective if taken with fundador..😂
Reuters Sinovac says... Sinovac says. Oh yeah, where's the data?
Philippines Latest News, Philippines Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.